Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,656 | 22,465 | 46,345 | 64,065 | 126,263 |
| Marketable Securities | 171,301 | 147,561 | 92,012 | 22,678 | 26,012 |
| Receivables | 3,473 | 1,010 | 28 | 14 | 395 |
| Inventories | 231 | 381 | N/A | N/A | N/A |
| TOTAL | $246,193 | $176,547 | $140,866 | $88,921 | $157,719 |
| Non-Current Assets | |||||
| PPE Net | 2,484 | 1,987 | 2,071 | 1,176 | 295 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 5,200 | 6,352 | 6,819 | 2,269 | 1,231 |
| TOTAL | $52,227 | $52,882 | $53,433 | $47,988 | $46,069 |
| Total Assets | $298,420 | $229,429 | $194,299 | $136,909 | $203,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 11,646 |
| Accounts payable and accrued liabilities | 14,801 | 14,389 | 10,395 | 9,152 | 5,469 |
| Accrued Expenses | 30,447 | 17,157 | 12,777 | 12,972 | 29,691 |
| TOTAL | $45,248 | $31,546 | $23,172 | $22,124 | $46,806 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,298 | 99,508 | 48,579 | N/A | N/A |
| Other Non-Current Liabilities | 6,924 | 5,265 | 5,424 | 1,190 | 611 |
| TOTAL | $107,222 | $104,773 | $54,003 | $1,190 | $611 |
| Total Liabilities | $152,470 | $136,319 | $77,175 | $23,314 | $47,417 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 361,492 | 246,237 | 188,726 | 149,594 | 144,354 |
| Common Shares | 363 | 245 | 189 | 150 | 142 |
| Retained earnings | -1,967,242 | -1,766,839 | -1,589,720 | -1,487,776 | -1,400,018 |
| Other shareholders' equity | 504 | 146 | -489 | 472 | 151 |
| TOTAL | $145,950 | $93,110 | $117,124 | $113,595 | $156,371 |
| Total Liabilities And Equity | $298,420 | $229,429 | $194,299 | $136,909 | $203,788 |